Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.08 USD | -1.69% | -5.40% | +16.56% |
May. 22 | Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing | MT |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
Financials (USD)
Sales 2024 * | 951M | Sales 2025 * | 1.1B | Capitalization | 5.48B |
---|---|---|---|---|---|
Net income 2024 * | 373M | Net income 2025 * | 466M | EV / Sales 2024 * | 6.71 x |
Net Debt 2024 * | 899M | Net Debt 2025 * | 422M | EV / Sales 2025 * | 5.38 x |
P/E ratio 2024 * |
14.2
x | P/E ratio 2025 * |
11.2
x | Employees | 373 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.89% |
Latest transcript on Halozyme Therapeutics, Inc.
1 day | -1.69% | ||
1 week | -5.40% | ||
Current month | +13.07% | ||
1 month | +11.69% | ||
3 months | +8.54% | ||
6 months | +8.57% | ||
Current year | +16.56% |
Managers | Title | Age | Since |
---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 61 | 14-01-05 |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 14-12-31 |
Mark Snyder
CMP | Compliance Officer | 57 | 22-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
BRD | Director/Board Member | 70 | 06-07-30 |
Chairman | 59 | 15-08-04 | |
Barbara Duncan
BRD | Director/Board Member | 59 | 23-02-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.48% | 5 M€ | -1.80% | - | |
0.73% | 0 M€ | 0.00% | - | |
0.55% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 43.08 | -1.69% | 1,031,547 |
24-05-24 | 43.82 | -0.23% | 898,705 |
24-05-23 | 43.92 | -3.43% | 1,172,741 |
24-05-22 | 45.48 | -0.13% | 843,320 |
24-05-21 | 45.54 | +1.27% | 915,149 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.56% | 5.48B | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.69% | 21.83B | |
-10.23% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- HALO Stock